You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services.
Congress has passed a piece of legislation supporting marijuana research, and more significantly, will be holding a floor vote on the Marijuana Opportunity, Reinvestment, and Expungement Act next week.
Tilray and other Canadian cannabis companies need federal legalization in the United States to realize the full potential of markets they want to serve.
The Senate also approved another marijuana bill on Thursday.
Dianne Feinstein said in a statement: “Current rules and regulations make it hard for researchers to study how marijuana and marijuana-derived medications can best be used to treat various conditions.